title: [Controversy. Dabigatran in the preventive treatment of embolic stroke: arguments against its utilisation as a first-choice drug].
authors.affiliation: Hospital Universitario Central de Asturias, Oviedo, Espana. scallejap@gmail.com
authors.forename: S
authors.initials: S
authors.lastname: Calleja-Puerta
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D000069604:Dabigatran; D006801:Humans; D020766:Intracranial Embolism / Q000150:complications / Q000517:prevention & control*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran